ehealth radio network
Episodes
Friday Apr 23, 2021
Friday Apr 23, 2021
Scott Megill, President and CEO at Coriell Life Sciences, a precision medicine company using genetic science and research to improve lives, reduce healthcare costs, and simplify decision-making for its customers joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels & guest Scott Megill discuss the following:
Who is Coriell Life Sciences?
How does Coriell Life Sciences partner with the healthcare community to deliver paths to better health?
What makes Coriell Life Sciences unique?
How can individuals benefit from participating in Coriell Life Sciences’ medication safety program?
What’s the biggest opportunity for the healthcare ecosystem when it comes to personalized medicine?
Medications don’t work for everyone. Nearly one-third of U.S. adults take five or more prescription drugs and, even when taken correctly, they can be dangerous for many. Payers, providers, and patients bear the financial and physical burdens of inappropriate, ineffective drugs. Each year medication errors lead to 128,000 deaths and the costs of medication-associated errors exceed $40 billion in the U.S. alone. The cost of getting medications wrong reverberates through the healthcare service model and echoes back as wasted resources, time, and poor health.
For hundreds of medications, successful treatment is directly related to an individual’s DNA. Natural variation in our genetic code can cause the same drug to produce different effects on different people. The science of pharmacogenomics (PGx) can now assist in assessing how each person will respond to medications, however, DNA testing alone is not sufficient. That’s why Coriell Life Sciences (CLS) leverages advanced, proprietary technology to bridge the gap between genetic knowledge and clinical application. Building on six decades of research, CLS developed a cutting-edge bioinformatics solution that interprets pharmacogenomic laboratory results and couples them with traditional medication management risk factors to deliver a dynamic regimen modeling tool.
Driving innovation in precision medicine, CLS unlocks the power of genetic science to provide actionable insights for employers, payers, healthcare providers, physicians, pharmacists, laboratories, and patients, that enable more effective and efficient care.
Backed by rigorous scientific methodology, Corigen™, CLS’ population-scale medication safety program, is the most comprehensive medication safety solution on the market. This novel solution is powered by CLS’s real-time medication decision support modeling tool, GeneDose LIVE. This unique system provides physicians with updated medication risk information for their patients’ current medication regimen and offers alternatives for safer therapy, all in real-time. GeneDose LIVE also provides risk analysis of non-genetic factors such as lifestyle, drug interactions, age-related risks, and other concerns, along with a personalized medication action plan (MAP) that reveals which medications are best suited for an individual.
By matching people with the right medications, CLS enables patients to benefit from fewer hospitalizations, less unneeded testing, and reduced doctor’s visits, ultimately decreasing healthcare costs. Most importantly, CLS reduces costly trial-and-error experimentation and speeds patients’ return to good health.
Recognized as a leader in precision medicine and health innovation—including IBM’s Entrepreneur of the Year—CLS leverages its influence to advocate for the advancement of precision medicine. The organization is highly active with the American Society of Pharmacovigilance, the Personalized Medicine Coalition, a signing member of the Get the Medications Right Institute, and passionate about educating stakeholder groups through the Population Health Colloquium, Health Action Council, Employer Health Innovation Roundtable, and various other platforms.
As CLS collaborates with major healthcare providers to empower the most precise medical care, the organization is continually pushing the boundaries of what’s possible—serving as the gold standard in knowledge and understanding of pharmacogenomics.
Website: https://coriell.com
Linkedin Links: Company LinkedIn: linkedin.com/company/corielllife Personal LinkedIn: linkedin.com/in/scottmegill
Thursday Apr 08, 2021
Thursday Apr 08, 2021
Karly Rowe, Vice President of Patient Access, Identity & Care Management Product for Experian Health that works with more than 3,200 hospitals and 10,000 other healthcare organizations representing 500,000 plus providers to provide data-driven solutions that support revenue cycle management, identity management, patient engagement and care management joins eHealth Radio and the Health Care and Health News Channels.
Listen to interview with host Eric Michaels and guest Karly Rowe discuss the following:
Can you tell us about Experian Health and your role within the company?
Any discussion of healthcare today is framed by the COVID-19 pandemic. From your business, your line of sight, what has the pandemic put in the spotlight?
In the early days of the pandemic, some of our healthcare organizations estimated 1,800 duplicate records were being created every 24 hours, so it is a fair bet that the numbers are even greater now as people flock to schedule vaccines. How does the growing volume of patient traffic challenge our healthcare systems?
How would a shift to standardized medical records, possibly even a universal patient ID number, help healthcare systems and health outcomes?
What direction is the industry headed and what pain points are you solving for as you look to the future?
Summary: While approximately 25% of patients used patient portals prior to COVID-19, more than 235 million adults will likely interact with a patient portal or telehealth service for the first time. This new interaction sparks opportunity – an opportunity for patients to think differently about the role they are taking/playing in managing their health and an opportunity for healthcare organizations to think about how to build on and advance this newly formed relationship.
Karly Rowe is responsible for the Patient Access, Identity, and Care Management product portfolios at Experian Health. Leveraging her diverse background across credit, retail, and healthcare, Karly is responsible for finding new ways to leverage Experian’s data and analytical capabilities to develop new, innovative solutions for the healthcare industry.
Karly holds a Masters of Business Administration from Arizona State University and a Bachelor’s degree in Marketing Management and Retail Management from Syracuse University. She resides in Scottsdale, Arizona with her husband and two sons.
Website: experian.com/healthcare
Social Media Links: Twitter: twitter.com/Experian_Health Linkedin: linkedin.com/company/experian
Friday Mar 12, 2021
Why should everyone consider getting the COVID vaccine?
Friday Mar 12, 2021
Friday Mar 12, 2021
Dr. Shirin Peters, Founder and Medical Director at Bethany Medical Clinic of New York, a primary care clinic network in New York City that provides primary and preventative care for busy New Yorkers at 8 clinic locations joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels & guest Dr. Shirin Peters discuss the following:
What is in the COVID vaccine?
How was the COVID vaccine developed, tested and mass produced in such a short time?
Can you get COVID from the COVID vaccine?
What did the Pfizer and Moderna clinical trials for the COVID vaccine show?
If I had COVID already, should I still get the COVID vaccine?
Dr. Shirin Peters a physician, and entrepreneur with 10 years experience in the business of outpatients medicine. She is well versed in standard of care for Primary Care medicine as well as the world of medical billing and health insurance. She considers herself an expert in creating care models that delight patients and meet their individual needs, as well as in managing healthcare providers and keeping them engaged and able to practice at their best.
Website: www.bmcofny.com
Social Media Links: Instagram: @bethanymedicalofny | @drshirinpetersTwitter: @drshirinpeters Linkedin: linkedin.com/in/shirin-peters
Monday Mar 08, 2021
How kindness can be a competitive edge in medical care
Monday Mar 08, 2021
Monday Mar 08, 2021
Dr. Larry Benz, the Co-Founder of Confluent Health, a network of physical therapy and occupational healthcare companies, and author of the best-selling book Called to Care: A Medical Provider’s Guide for Humanizing Healthcare joins eHealth Radio and the Health Care and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Larry Benz discuss the following:
The pandemic has shed light on some major challenges medical providers are facing. Outside of our current, tragic circumstances, what are some of the biggest challenges you’ve seen in the industry?
In your book, you posit that kindness can be a competitive edge for healthcare providers. Can you explain what you mean?
You cite a remarkable study that showed during 25% of visits, doctors don’t even ask patients what is bothering them. What is your best advice for patients who find themselves in an appointment like that?
With the popularity of tele-health options increasing during COVID, what are some tips for how practitioners can emphasize care and connection with patients remotely?
You’ve done a lot of work studying the impact of positive psychology in medical care. Can you talk us through the application of positive psychology, and how it can impact patient outcomes?
Dr. Larry Benz, PT, DPT, OCS, MBA, MAPP, is the co-founder of Confluent Health, a network of physical therapy and occupational healthcare companies dedicated to educating and developing highly effective clinicians, strengthening private practice, reducing healthcare costs, and preserving care in healthcare.
A frequent lecturer at Physical Therapy programs, national conferences, and MBA schools throughout the country, Dr. Benz trained at Baylor University and the University of Pennsylvania. He is a nationally recognized award recipient for his expertise in private-practice Physical Therapy and occupational medicine.
As the co-developer of Jacmel Rehabilitation, Dr. Benz and his colleagues at Confluent Health and other various organizations have built a sustainable physical rehabilitation clinic in Haiti. For more information, please visit PThelpforHaiti.org and CalledtoCarebook.com.
Website: calledtocarebook.com
Social Media Links: Facebook: facebook.com/LarryBenz Instagram: instagram.com/physicaltherapist Linkedin: linkedin.com/in/lbenz
Wednesday Dec 23, 2020
Wednesday Dec 23, 2020
Michael Feldschuh, the CEO of Daxor, an innovative medical instrumentation and biotechnology company focused on blood volume measurement joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Michael Feldschuh discuss the following:
Can you tell me a bit about yourself and how you got interested in the medical technology field that led to your involvement with Daxor?
Let’s talk about BVA-100 and its benefits to physicians? How does BVA-100 differentiate from other similar technologies?
How does BVA-100 allow clinicians to provide better outcomes for their patients?
Are there any recent studies that validate BVA?
Please give us an overview of BVA-100 and how it improves outcomes for heart failure patients?
Daxor Corporation (NYSE: DXR) is an innovative medical instrumentation and biotechnology company focused on blood volume measurement. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology has the potential to improve hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved patient outcomes. Our mission is to partner with clinicians to incorporate BVA technology into standard clinical practice and improve the quality of life for patients.
Website: www.daxor.com
Social Media Links: Facebook: facebook.com/Daxorcorp Linkedin: linkedin.com/company/daxorcorporation Twitter: twitter.com/DaxorBVA
Friday Dec 18, 2020
The Future of Medical Recalls
Friday Dec 18, 2020
Friday Dec 18, 2020
Joan Melendez, the Founder and President at health-tech startup Xcelrate UDI joins eHealth Radio and the Health News and Technology Channels. Their technology, a medical device barcode scanning solution, identifies and prevents the use of recalled and faulty medical products and devices to improve patient safety at the point of care.
Listen to interview with host Eric Michaels and guest Joan Melendez discuss the following:
What is a Unique Device Identifier, and why has it become so relevant in recent times?
What kind of impact are medical recalls currently having on the healthcare industry and patients?
How could full-scale adoption of your barcode scanning technology change healthcare - for patients and the industry as a whole?
How can technology be better used across healthcare -- for communication, organisation, data storage?
The Closed Loop Automation Solution you’ve partnered on has introduced an electronic patient implant card. How will this benefit patients?
Tip: If you’ve had a medical device implanted or are about to, ask your doctor about how they are ensuring your implants are safe for use and how you will be notified of quality issues should your implants be recalled after they are implanted.
Founder and President Joan Melendez leads the team at Xcelrate UDI. Having been in the healthcare industry since her teens, Joan has become a passionate advocate for the safety of patients and for innovation in healthcare.
Xcelrate UDI is a healthcare technology and consulting services company that leverages the power of UDI (unique device identifier) barcode scanning technology to bridge the information gaps between data sources (provided by manufacturers and the FDA) for medical devices and physical supplies. Their vision? To be the industry’s most trusted partner in advancing UDI adoption to improve compliance with medical devices and reduce patient risk at the point of care.
Website: www.xcelrateudi.com
Social Media Links: Facebook: facebook.com/xcelrateudi Linkedin: linkedin.com/company/xcelrate-udi Instagram: instagram.com/xcelrateudi
Wednesday Dec 16, 2020
Research shows that honey can be effective with respiratory illness
Wednesday Dec 16, 2020
Wednesday Dec 16, 2020
Dr. Baljit Khamba, a clinic supervisor at Bastyr University Clinic and a core faculty member at Bastyr University California joins eHealth Radio and the Health News Channel.
Bastyr University is a nonprofit, private university offering doctoral, graduate and undergraduate degrees, with a multidisciplinary curriculum in science-based natural medicine. Recognized globally for its rigorous curriculum and strong research, the 42-year-old University has campuses in Kenmore, Washington, and San Diego, California. Bastyr's international faculty educate future leaders in the natural health arts and sciences, with an emphasis on integrating mind, body, spirit and nature.
Listen to interview with host Eric Michaels and guest Dr. Baljit Khamba discuss the following:
Tell us how you and your colleagues came to this research idea.
What evidence did the research show that honey can be effective with respiratory illness?
Why is your immunity and respiratory health important right now?
How can you incorporate honey into your daily routine to support your immune system?
What are other ways people can boost their immune system?
Dr. Baljit Khamba is a clinic supervisor at Bastyr University Clinic and a core faculty member at Bastyr University California. She treats a variety of conditions but has special interest in nutritional approaches to anxiety, stress, depression, focus and attention, memory and cognition. She focuses on providing high quality care addressing the causes of disease and utilizes safe and effective natural treatments. She accepts patients and their families who are motivated to improve their health. Her emphasis is on disease prevention and health promotion through education and empowering her patients to become active participant in the management of their own health.
While completing bachelor and master’s degrees, she worked as a research analyst at the Centre for Addiction and Mental Health (CAMH), where she researched alcohol addiction and anxiety, as well as nutrition and mental health. Dr. Khamba also has experience working in integrative psychiatric clinics, as well as more generalized practice, as well as being involved with research projects at the University of Alberta on natural health product safety in psychiatric patients. Dr. Khamba also maintains a private telemedicine practice.
Websites: https://bastyr.edu | https://bastyrclinic.org
Saturday Nov 28, 2020
No Cost Covid-19 Antibody Community Testing with Dr. Harrington, MD
Saturday Nov 28, 2020
Saturday Nov 28, 2020
Dr. Douglas S. Harrington, MD Fellow of the American Society of Preventive Cardiology, and the American Society of Clinical Pathology, who is an expert in laboratory diagnostic testing joins eHealth Radio and the Health Care and Health News Channels. Dr. Harrington is also the Chairman of the GUARDaHEART Foundation 501(c)3 who is actively partnering with community organizations, nonprofit organizations, businesses, and city officials to provide the community with No-Cost COVID-19 Antibody Tests covered under the CARES Act.
Listen to interview with host Eric Michaels and guest Dr. Douglas S. Harrington discuss the following:
What is GUARDaHEART Foundation’s goal in partnering with the community to provide the SARS-CoV-2 Antibody Test?
What is the difference between a COVID-19 swab test vs and COVID-19 SARS-CoV-2 antibody test?
Who should take the antibody test and what are the benefits of having the test?
What is the difference between IgG and IgM antibodies and how long does it take to develop antibodies?
How long do the antibodies stay in my body?
If my antibody report results positive, am I immune to COVID-19?
What happens if someone tests positive for the COVID-19 Antibodies? Should they be quarantined?
Is it true that the Latin Community and African American Community have the highest rates of COVID? If so, why is that?
What is the correlation of heart disease and coronavirus?
Tell us about the SARS-CoV-2 serology antibody test being provided with a sensitivity of 100% and a specificity of 99.6% based on initial performance evaluations. Is this more reliable than other tests being provided?
Are there natural medicines that aim to help to reduce an individual from getting the virus?
Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington was a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. Heco-founded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma StudyGroup headed by Dr. Jim Armitage. As President and Lab Director of Nichols Institute, Dr. Harrington expanded their molecular genetics, infectious disease, immunology,cytogenetic, and anatomic pathology offerings. Dr. Harrington led the team that developed one of the first digital microscopes targeted at minimal residual disease and circulating tumor cells as the founder and CEO of Clarient. Dr.Harrington also led the turnaround and reinstatement of theFederal license of Specialty Laboratories, a New York StockExchange company, as CEO and Laboratory Director.
Dr. Harrington has developed patents for an automated method for image analysis of residual cancer cells, a patent covering catalytic heavy metal extraction, and a patent pending on biomarker assay for diagnosis and classification of cardiac disease. He has been involved as director or founder of multiple startup companies - from devices to molecular genetics focusing on immunology, cancer and cardiology,where he has taken a number of new molecular technologies through state and federal regulatory approval, and has been involved in the commercialization of over 200 academic discoveries. He is a member of Phi Beta Kappa, the nation’s most prestigious academic honor society.
Dr. Harrington is the inventor of the PULS Cardiac Test (TM) ,a breakthrough blood test for the detection of the leading cause of heart attacks, and CEO & Laboratory Director ofGlobal Discovery Biosciences. Throughout his career Dr.Harrington has remained a Clinical Professor of Pathology at the USC Keck School of medicine, a published author of numerous peer-reviewed papers, and a sought after speaker in the area of preventive medicine and technology development. Dr. Harrington received his BA in molecular biology, his MD from the University of Colorado HealthSciences Center, and is a board-certified in hematology,anatomic and clinical pathology.
Website: www.guardaheart.org
Social Media Links: Facebook: facebook.com/Guardaheartfoundation Twitter: twitter.com/guardaheartorg
Wednesday Oct 28, 2020
How To Pivot Your Practice During The Pandemic
Wednesday Oct 28, 2020
Wednesday Oct 28, 2020
Dr. Patrick McEneaney, Founder and CEO of Northern Illinois Foot & Ankle Specialists joins eHealth Radio and the Foot Health and Health News Channels. Northern Illinois Foot and Ankle physicians, doctors, and surgeons diagnose and treat complex pediatric and adult foot and ankle conditions, providing their patients with the latest in treatment options to maximize outcomes.
Listen to interview with host Eric Michaels and guest Dr. Patrick McEneaney discuss the following:
What are some ways Northern Illinois Foot and Ankle has pivoted or helped during the pandemic?
What were some expectations you had behind expanding to the COVID-19 Lab & Testing Center?
What important information should people know about the Northern Illinois Lab & Testing Centers?
Are there any requirements for testing?
What is the turnaround for testing results?
Next month is Diabetes Awareness month, can you share with us more on why awareness for diabetes is so important?
If you are diabetic, how are your feet impacted?
What are ways you help diabetics manage their symptoms?
Dr. Patrick McEneaney is a board-certified DPM, owner, and CEO of Northern Illinois Foot & Ankle Specialist. Dr. McEneaney has a unique story being a young entrepreneur under 45 y/o with ten clinics and plans to expand, all while still practicing in foot and ankle care during a global pandemic. As the current president of the Illinois Podiatric Medical Association and Medical Director & Principal Investigator of NF&A, he has garnered numerous literature journal publications. His specialties involve advanced reconstructive surgery of foot & ankle dealing with flatfoot reconstruction, post-traumatic injury management, deformity correction, and wound care/limb salvage. Along with experience in diabetes and senior health care.
Website: https://illinoisfoot.com
Social Media Links: Facebook: facebook.com/Illinoisfoot Instagram: instagram.com/northern_illinois_foot_ankle Linkedin: linkedin.com/company/illinoisfoot
Saturday Oct 17, 2020
Saturday Oct 17, 2020
Ethan Davidoff, CEO and founder of Atlas Health, the leader in philanthropic reimbursement that empowers health systems with an end-to-end solution for enrolling patients in medical financial aid programs joins eHealth Radio and the Health News and the Health Care Channels.
Listen to interview with host Eric Michaels and guest Ethan Davidoff discuss the following:
Please tell our audiences about Atlas Heath, its goals and who it serves.
Tell us about the Navigator 4.0, and the services and benefits it will provide to health systems and its users.
What are your relationships with healthcare payers and philanthropic relief programs designated to help aid hospital systems during the COVID-19 pandemic?
What benefits can Navigator 4.0 offer to 340B hospital systems who are experiencing the significant rate cuts during these unprecedented times?
Are there any financial risks to employers or hospital systems may be facing right now that Navigator 4.0 is working to solve?
Hospital systems are desperate for any type of aid during the COVID-19 pandemic. What other ways can your services provide relief for hospitals struggling with financial pressures?
How can patients who have lost their jobs and health insurance due to the COVID-19 economic crisis benefit from Atlas' Navigator 4.0 in terms of longevity?
Does Atlas’ Navigator 4.0 plan on providing relief for urgent care or walk-in clinics that receive patients for COVID-19 testing or intervention?
COVID-19 patients often also experience other related illnesses. What other ways can your services provide treatment and ensure patients will be financially and medically protected?
How have you been trying to educate under-served populations on your services? Please describe how Atlas’ Navigator 4.0 will help with the challenges for under-served populations with access to primary care services?
Atlas Health, the leader in philanthropic reimbursement, is improving and saving lives by empowering providers with an end-to-end solution for matching and enrolling patients in medical financial aid programs through its proprietary technology and AI-powered service partnership platform, Atlas Navigator. Patients receive the care they need and providers secure reimbursement for care delivered.
Ethan Davidoff is the Founder & CEO of Atlas Health with over 10 years of healthcare, enterprise software, and cyber security experience. Ethan Davidoff founded Atlas Health in 2017 and maintains the role of CEO. Under his direction, the company has become the leader in philanthropic reimbursement.
Prior to Atlas Health, Davidoff was a founding member of RiskIQ. Serving as Vice President and General Manager of Internet Security, he managed a cross-functional team to grow an emerging business unit with fortune 500 and top technology companies.
Davidoff studied business, entrepreneurship, and software development at the University of California at Berkeley and the London School of Economics.
Website: https://atlas.health
Linkedin: linkedin.com/company/atlashealth